The Europe Upper Extremity Implants Market would witness market growth of 5.8% CAGR during the forecast period (2023-2029).
In the context of generative manufacturing, selective laser melting (SLM) is a 3D printing technique. With the help of a scraper or roller, titanium particulate is transferred from a high-pressure chamber to a working chamber. Then, a mirror reflects a laser beam into the working chamber, where it strikes titanium particles. The laser beam's impact melts and compacts the material (hence the term laser melting). After the laser has finished processing one working plane, the working platform (table) descends, and a new layer of titanium powder is deposited to the surface of the working plane. As a result, the item is created by adding successive layers.
The three-dimensional workpieces that are produced as a result of the laser are incredibly compressed. This is because the laser has an extraordinarily high-performance density. This manufacturing method makes it possible to fabricate titanium implants that are customized for each individual patient. Additionally, selective laser sintering and stereolithography are generative manufacturing techniques. The only distinction between selective laser sintering (SLS) and selective laser melting (SLM) is that all the starting materials used in SLS have thermoplastic properties. Resin granules, such as polyamide (PA), are common. Using this procedure, drill and marking guides or anatomical models are created.
In 2017, MSK diseases were frequent across all age groups in the UK. Wales had a 29.3% (887,000) population, Scotland had a 29.1% (487,200), and England had a 30.1% (15,899,000) population. MSK diseases, which impact the joints, bones, muscles, and spine, frequently lead to physically disabled people experiencing terrible pain. Illnesses that produce inflammation, such as rheumatoid arthritis, discomfort in the MSK, osteoporosis, and fragility fractures. Even though life expectancy has increased, many people—especially those in less wealthy parts of the nation—are living longer in declining health. The demand is expected to surge as the prevalence of MSK rises due to their ability to assist people suffering from such disorders, which will aid market growth in Europe.
The Germany market dominated the Europe Upper Extremity Implants Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $150 million by 2029. The UK market is anticipated to grow at a CAGR of 4.9% during (2023 - 2029). Additionally, The France market would showcase a CAGR of 6.6% during (2023 - 2029).
Based on Material, the market is segmented into Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials and Natural Biomaterials. Based on Type, the market is segmented into Shoulder, Elbow and Hand & Wrist. Based on End-use, the market is segmented into Hospitals, Clinics and ASCs'. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Upper Extremity Implants Market is Projected to reach USD 2.3 Billion by 2029, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, DePuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, Medtronic PLC, Aesculap, Inc. (B. Braun Melsungen AG), DJO Global (Enovis Corporation), Ossur Hf., Acumed LLC (Colson Medical, Inc.) and Arthrex, Inc.
By Material
By Type
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
